CLoNeT™ 1.0

About ID Genomics

ID Genomics is a private, pre-revenue diagnostics company tackling the global antibiotic resistance crisis through a proprietary platform that 'barcodes' bacterial strains to predict drug susceptibility. Its lead product, CLoNeT™, is in development for urinary tract infections (UTIs) and has shown promising preclinical results in dramatically reducing prescription errors. The company complements its assay development with a growing big-data repository, BactNet™, and offers a suite of microbial genomic analysis services. Its approach aims to shift infectious disease management from empirical treatment to precise, data-driven therapy.

Therapeutic Areas